NCT05375734
- Conditions
- Immunotherapy, Pulmonary Pleomorphic Carcinoma, Tislelizumab
- Locations
-
- The Second Afiliated Hospital of Nanchang University Nanchang, Jiangxi, China
Clinical trial condition
Pulmonary Pleomorphic Carcinoma
Explore clinical trials studying Pulmonary Pleomorphic Carcinoma. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies